Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2‑((4-(Benzo[d]-thiazol-5-ylamino)-6‑(tert-butylsulfonyl)-quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of...

Autor:	Haile, Pamela A., Casillas, Linda N., Votta, Bartholomew J., Wang, Gren Z., Charnley, Adam K., Dong, Xiaoyang, Bury, Michael J., Romano, Joseph J., Mehlmann, John F., King, Bryan W., Erhard, Karl F., Hanning, Charles R., Lipshutz, David B., Desai, Biva M., Capriotti, Carol A., Schaeffer, Michelle C., Berger, Scott B., Mahajan, Mukesh K., Reilly, Michael A., Nagilla, Rakesh
Zdroj:	Journal of Medicinal Chemistry; 7/25/2019, Vol. 62 Issue 14, p6482-6494, 13p
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu